Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.32 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.32 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6581440 | 0.77 | FAAH (0.58) | FAAHMAPTHTTATMELANE | |
| SCHEMBL14994169 | 0.75 | FAAH (1.00) | FAAHMAPTHTTATMELANE | |
| SCHEMBL26803354 | 0.72 | — | — | |
| SCHEMBL29196133 | 0.68 | FAAH (0.41) | FAAHMAPTHTTATMNR1H2 | |
| SCHEMBL1864917 | 0.67 | FAAH (0.40) | FAAHELANENR1H2USP2SMN1; SMN2 | |
| SCHEMBL5873836 | 0.66 | NR1H2 (0.43) | FAAHNR1H2SMARCA2SMARCA4PBRM1 | |
| SCHEMBL18063082 | 0.66 | NR1H2 (0.43) | FAAHMAPTNR1H2SMARCA2SMARCA4 | |
| SCHEMBL25519814 | 0.66 | FAAH (0.39) | FAAHELANENR1H2SMARCA2SMARCA4 | |
| SCHEMBL18284944 | 0.66 | FAAH (0.39) | FAAHELANENR1H2SMARCA2SMARCA4 | |
| SCHEMBL25293645 | 0.66 | ELANE (0.43) | FAAHHTTATMELANENR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090155862-A1 | Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols | LONZA AG (CH) | 2009-06-18 | — | — | US | disclosed |
| EP-1379676-B1 | PROCESS FOR THE PREPARATION OF 2-HYDROXYMETHYL-PYROLIDINE-3,4-DIOLS | LONZA AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| US-20040185539-A1 | Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols | LONZA AG (CH) | 2004-09-23 | — | — | US | disclosed |
| EP-1379676-A2 | PROCESS FOR THE PREPARATION OF 2-HYDROXYMETHYL-PYROLIDINE-3,4-DIOLS | LONZA AG (CH) | 2004-01-14 | — | — | EP | disclosed |
| US-6576780-B1 | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors | GD SEARLE & COMPANY | 2003-06-10 | — | — | US | disclosed |
| WO-2002074737-A2 | PROCESS FOR THE PREPARATION OF 2-HYDROXYMETHYL-PYROLIDINE-3,4-DIOLS | LONZA AG (CH) | 2002-09-26 | — | — | WO | disclosed |
| US-6207708-B1 | FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, | G. D. SEARLE & COMPANY | 2001-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040185539-A1 | Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols | HPD, DHPS, DPYD | FAAH 2667/4885MAPT 3940/4885HTT 2532/4885 |
| US-20090155862-A1 | Process for the preparation of 2-hydroxymethyl-pyrrolidine-3,4-diols | HPD, DHPS, DPYD | FAAH 1590/4885MAPT 3500/4885HTT 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.